Literature DB >> 9550419

Second-hand smoke is an adjuvant for T helper-2 responses in a murine model of allergy.

B W Seymour1, K E Pinkerton, K E Friebertshauser, R L Coffman, L J Gershwin.   

Abstract

Epidemiologic studies have suggested that "second-hand smoke" increases the incidence and severity of allergies and asthma. To address this, we developed a murine model that included generation of and exposure to environmental tobacco smoke (ETS) followed by aerosolized Ag challenge. We report herein that exposure of OVA-sensitized BALB/c mice to ETS elicits a rapid and prolonged exaggerated response with respect to IgE, IgG1, eosinophils, and Th2 cytokines (particularly IL-4 and IL-10). There was a significant increase (p = 0.0159) in the total cells of the bronchoalveolar lavage in OVA-sensitized mice exposed to ETS when compared with those in ambient air. This is the first experimental data to demonstrate that "second-hand smoke" up-regulates the allergic response to inhaled Ag. The results have important health implications for children and allergic individuals residing in households with smokers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9550419

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibody.

Authors:  S M Koethe; J R Kuhnmuench; C G Becker
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

Review 2.  Pollution and the immune response: atopic diseases--are we too dirty or too clean?

Authors:  D Diaz-Sanchez
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

3.  Environmental tobacco smoke and progesterone alter lung inflammation and mucous metaplasia in a mouse model of allergic airway disease.

Authors:  Valerie L Mitchell; Laura S Van Winkle; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

4.  Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption.

Authors:  Wendy Cozen; David Diaz-Sanchez; W James Gauderman; John Zadnick; Myles G Cockburn; Parkash S Gill; Rizwan Masood; Ann S Hamilton; Minna Jyrala; Thomas M Mack
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

5.  Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis.

Authors:  Yan Feng; Ying Kong; Peter F Barnes; Fang-Fang Huang; Peter Klucar; Xisheng Wang; Buka Samten; Mayami Sengupta; Bruce Machona; Ruben Donis; Amy R Tvinnereim; Homayoun Shams
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

Review 6.  The role of environmental tobacco smoke in the origins and progression of asthma.

Authors:  Neil C Thomson
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

7.  High-dose but not low-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function.

Authors:  Thomas H Thatcher; Randi P Benson; Richard P Phipps; Patricia J Sime
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-06-20       Impact factor: 5.464

8.  Wheeze associated with prenatal tobacco smoke exposure: a prospective, longitudinal study. ALSPAC Study Team.

Authors:  A L Lux; A J Henderson; S J Pocock
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

9.  Cigarette smoking, passive smoking, and non-Hodgkin lymphoma risk: evidence from the California Teachers Study.

Authors:  Yani Lu; Sophia S Wang; Peggy Reynolds; Ellen T Chang; Huiyan Ma; Jane Sullivan-Halley; Christina A Clarke; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2011-07-18       Impact factor: 4.897

10.  Acrolein inhalation suppresses lipopolysaccharide-induced inflammatory cytokine production but does not affect acute airways neutrophilia.

Authors:  David Itiro Kasahara; Matthew E Poynter; Ziryan Othman; David Hemenway; Albert van der Vliet
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.